Global Prostate Cancer Diagnostics Market Insights and Forecast to 2027

Publisher Name :
Date: 12-May-2021
No. of pages: 116
Inquire Before Buying

Prostate Cancer Diagnostics market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Prostate Cancer Diagnostics market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2016-2027.

Segment by Type

- Tumor Biomarker Tests

- Imaging

- Biopsy

- Other

Segment by Application

- age Below 55

- age 55-75

- age Above 75

By Company

- Genomic Health

- Abbott

- OPKO

- Siemens Healthcare

- DiaSorin

- BioMeriux

- Roche

- MDx Health

- Beckman Coulter

- Myriad Genetics

- Ambry Genetics

By Region

- North America

- - U.S.

- - Canada

- Europe

- - Germany

- - France

- - U.K.

- - Italy

- - Russia

- Asia-Pacific

- - China

- - Japan

- - South Korea

- - India

- - Australia

- - Taiwan

- - Indonesia

- - Thailand

- - Malaysia

- - Philippines

- - Vietnam

- Latin America

- - Mexico

- - Brazil

- - Argentina

- Middle East & Africa

- - Turkey

- - Saudi Arabia

Global Prostate Cancer Diagnostics Market Insights and Forecast to 2027

Table of Contents
1 Study Coverage
1.1 Prostate Cancer Diagnostics Product Introduction
1.2 Market by Type
1.2.1 Global Prostate Cancer Diagnostics Market Size Growth Rate by Type
1.4.2 Tumor Biomarker Tests
1.4.3 Imaging
1.2.4 Biopsy
1.2.5 Other
1.3 Market by Application
1.3.1 Global Prostate Cancer Diagnostics Market Size Growth Rate by Application
1.3.2 age Below 55
1.3.3 age 55-75
1.3.4 age Above 75
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global Prostate Cancer Diagnostics Sales Estimates and Forecasts 2016-2027
2.2 Global Prostate Cancer Diagnostics Revenue Estimates and Forecasts 2016-2027
2.3 Global Prostate Cancer Diagnostics Revenue by Region: 2016 VS 2021 VS 2027
2.4 Global Top Prostate Cancer Diagnostics Regions by Sales
2.4.1 Global Top Prostate Cancer Diagnostics Regions by Sales (2016-2021)
2.4.2 Global Top Prostate Cancer Diagnostics Regions by Sales (2022-2027)
2.5 Global Top Prostate Cancer Diagnostics Regions by Revenue
2.5.1 Global Top Prostate Cancer Diagnostics Regions by Revenue (2016-2021)
2.5.2 Global Top Prostate Cancer Diagnostics Regions by Revenue (2022-2027)
2.6 North America
2.7 Europe
2.8 Asia-Pacific
2.9 Latin America
2.10 Middle East & Africa
3 Competition by Manufacturers
3.1 Global Prostate Cancer Diagnostics Sales by Manufacturers
3.1.1 Global Top Prostate Cancer Diagnostics Manufacturers by Sales (2016-2021)
3.1.2 Global Top Prostate Cancer Diagnostics Manufacturers Market Share by Sales (2016-2021)
3.1.3 Global Top 10 and Top 5 Companies by Prostate Cancer Diagnostics Sales in 2020
3.2 Global Prostate Cancer Diagnostics Revenue by Manufacturers
3.2.1 Global Top Prostate Cancer Diagnostics Manufacturers by Revenue (2016-2021)
3.2.2 Global Top Prostate Cancer Diagnostics Manufacturers Market Share by Revenue (2016-2021)
3.2.3 Global Top 10 and Top 5 Companies by Prostate Cancer Diagnostics Revenue in 2020
3.3 Global Prostate Cancer Diagnostics Sales Price by Manufacturers
3.4 Analysis of Competitive Landscape
3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Prostate Cancer Diagnostics Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4.3 Global Prostate Cancer Diagnostics Manufacturers Geographical Distribution
3.5 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global Prostate Cancer Diagnostics Sales by Type
4.1.1 Global Prostate Cancer Diagnostics Historical Sales by Type (2016-2021)
4.1.2 Global Prostate Cancer Diagnostics Forecasted Sales by Type (2022-2027)
4.1.3 Global Prostate Cancer Diagnostics Sales Market Share by Type (2016-2027)
4.2 Global Prostate Cancer Diagnostics Revenue by Type
4.2.1 Global Prostate Cancer Diagnostics Historical Revenue by Type (2016-2021)
4.2.2 Global Prostate Cancer Diagnostics Forecasted Revenue by Type (2022-2027)
4.2.3 Global Prostate Cancer Diagnostics Revenue Market Share by Type (2016-2027)
4.3 Global Prostate Cancer Diagnostics Price by Type
4.3.1 Global Prostate Cancer Diagnostics Price by Type (2016-2021)
4.3.2 Global Prostate Cancer Diagnostics Price Forecast by Type (2022-2027)
5 Market Size by Application
5.1 Global Prostate Cancer Diagnostics Sales by Application
5.1.1 Global Prostate Cancer Diagnostics Historical Sales by Application (2016-2021)
5.1.2 Global Prostate Cancer Diagnostics Forecasted Sales by Application (2022-2027)
5.1.3 Global Prostate Cancer Diagnostics Sales Market Share by Application (2016-2027)
5.2 Global Prostate Cancer Diagnostics Revenue by Application
5.2.1 Global Prostate Cancer Diagnostics Historical Revenue by Application (2016-2021)
5.2.2 Global Prostate Cancer Diagnostics Forecasted Revenue by Application (2022-2027)
5.2.3 Global Prostate Cancer Diagnostics Revenue Market Share by Application (2016-2027)
5.3 Global Prostate Cancer Diagnostics Price by Application
5.3.1 Global Prostate Cancer Diagnostics Price by Application (2016-2021)
5.3.2 Global Prostate Cancer Diagnostics Price Forecast by Application (2022-2027)
6 North America
6.1 North America Prostate Cancer Diagnostics Market Size by Type
6.1.1 North America Prostate Cancer Diagnostics Sales by Type (2016-2027)
6.1.2 North America Prostate Cancer Diagnostics Revenue by Type (2016-2027)
6.2 North America Prostate Cancer Diagnostics Market Size by Application
6.2.1 North America Prostate Cancer Diagnostics Sales by Application (2016-2027)
6.2.2 North America Prostate Cancer Diagnostics Revenue by Application (2016-2027)
6.3 North America Prostate Cancer Diagnostics Market Size by Country
6.3.1 North America Prostate Cancer Diagnostics Sales by Country (2016-2027)
6.3.2 North America Prostate Cancer Diagnostics Revenue by Country (2016-2027)
6.3.3 U.S.
6.3.4 Canada
7 Europe
7.1 Europe Prostate Cancer Diagnostics Market Size by Type
7.1.1 Europe Prostate Cancer Diagnostics Sales by Type (2017-2027)
7.1.2 Europe Prostate Cancer Diagnostics Revenue by Type (2017-2027)
7.2 Europe Prostate Cancer Diagnostics Market Size by Application
7.2.1 Europe Prostate Cancer Diagnostics Sales by Application (2017-2027)
7.2.2 Europe Prostate Cancer Diagnostics Revenue by Application (2017-2027)
7.3 Europe Prostate Cancer Diagnostics Market Size by Country
7.3.1 Europe Prostate Cancer Diagnostics Sales by Country (2017-2027)
7.3.2 Europe Prostate Cancer Diagnostics Revenue by Country (2017-2027)
7.3.3 Germany
7.3.4 France
7.3.5 U.K.
7.3.6 Italy
7.3.7 Russia
8 Asia Pacific
8.1 Asia Pacific Prostate Cancer Diagnostics Market Size by Type
8.1.1 Asia Pacific Prostate Cancer Diagnostics Sales by Type (2018-2027)
8.1.2 Asia Pacific Prostate Cancer Diagnostics Revenue by Type (2018-2027)
8.2 Asia Pacific Prostate Cancer Diagnostics Market Size by Application
8.2.1 Asia Pacific Prostate Cancer Diagnostics Sales by Application (2018-2027)
8.2.2 Asia Pacific Prostate Cancer Diagnostics Revenue by Application (2018-2027)
8.3 Asia Pacific Prostate Cancer Diagnostics Market Size by Region
8.3.1 Asia Pacific Prostate Cancer Diagnostics Sales by Region (2018-2027)
8.3.2 Asia Pacific Prostate Cancer Diagnostics Revenue by Region (2018-2027)
8.3.3 China
8.3.4 Japan
8.3.5 South Korea
8.3.6 India
8.3.7 Australia
8.3.8 Taiwan
8.3.9 Indonesia
8.3.10 Thailand
8.3.11 Malaysia
8.3.12 Philippines
9 Latin America
9.1 Latin America Prostate Cancer Diagnostics Market Size by Type
9.1.1 Latin America Prostate Cancer Diagnostics Sales by Type (2019-2027)
9.1.2 Latin America Prostate Cancer Diagnostics Revenue by Type (2019-2027)
9.2 Latin America Prostate Cancer Diagnostics Market Size by Application
9.2.1 Latin America Prostate Cancer Diagnostics Sales by Application (2019-2027)
9.2.2 Latin America Prostate Cancer Diagnostics Revenue by Application (2019-2027)
9.3 Latin America Prostate Cancer Diagnostics Market Size by Country
9.3.1 Latin America Prostate Cancer Diagnostics Sales by Country (2019-2027)
9.3.2 Latin America Prostate Cancer Diagnostics Revenue by Country (2019-2027)
9.3.3 Mexico
9.3.4 Brazil
9.3.5 Argentina
6 Middle East and Africa
6.1 Middle East and Africa Prostate Cancer Diagnostics Market Size by Type
6.1.1 Middle East and Africa Prostate Cancer Diagnostics Sales by Type (2016-2027)
6.1.2 Middle East and Africa Prostate Cancer Diagnostics Revenue by Type (2016-2027)
6.2 Middle East and Africa Prostate Cancer Diagnostics Market Size by Application
6.2.1 Middle East and Africa Prostate Cancer Diagnostics Sales by Application (2016-2027)
6.2.2 Middle East and Africa Prostate Cancer Diagnostics Revenue by Application (2016-2027)
6.3 Middle East and Africa Prostate Cancer Diagnostics Market Size by Country
6.3.1 Middle East and Africa Prostate Cancer Diagnostics Sales by Country (2016-2027)
6.3.2 Middle East and Africa Prostate Cancer Diagnostics Revenue by Country (2016-2027)
6.3.3 Turkey
6.3.4 Saudi Arabia
6.3.5 U.A.E
11 Company Profiles
11.1 Genomic Health
11.1.1 Genomic Health Corporation Information
11.1.2 Genomic Health Overview
11.1.3 Genomic Health Prostate Cancer Diagnostics Sales, Price, Revenue and Gross Margin (2016-2021)
11.1.4 Genomic Health Prostate Cancer Diagnostics Product Description
11.1.5 Genomic Health Related Developments
11.2 Abbott
11.2.1 Abbott Corporation Information
11.2.2 Abbott Overview
11.2.3 Abbott Prostate Cancer Diagnostics Sales, Price, Revenue and Gross Margin (2016-2021)
11.2.4 Abbott Prostate Cancer Diagnostics Product Description
11.2.5 Abbott Related Developments
11.3 OPKO
11.3.1 OPKO Corporation Information
11.3.2 OPKO Overview
11.3.3 OPKO Prostate Cancer Diagnostics Sales, Price, Revenue and Gross Margin (2016-2021)
11.3.4 OPKO Prostate Cancer Diagnostics Product Description
11.3.5 OPKO Related Developments
11.4 Siemens Healthcare
11.4.1 Siemens Healthcare Corporation Information
11.4.2 Siemens Healthcare Overview
11.4.3 Siemens Healthcare Prostate Cancer Diagnostics Sales, Price, Revenue and Gross Margin (2016-2021)
11.4.4 Siemens Healthcare Prostate Cancer Diagnostics Product Description
11.4.5 Siemens Healthcare Related Developments
11.5 DiaSorin
11.5.1 DiaSorin Corporation Information
11.5.2 DiaSorin Overview
11.5.3 DiaSorin Prostate Cancer Diagnostics Sales, Price, Revenue and Gross Margin (2016-2021)
11.5.4 DiaSorin Prostate Cancer Diagnostics Product Description
11.5.5 DiaSorin Related Developments
11.6 BioMeriux
11.6.1 BioMeriux Corporation Information
11.6.2 BioMeriux Overview
11.6.3 BioMeriux Prostate Cancer Diagnostics Sales, Price, Revenue and Gross Margin (2016-2021)
11.6.4 BioMeriux Prostate Cancer Diagnostics Product Description
11.6.5 BioMeriux Related Developments
11.7 Roche
11.7.1 Roche Corporation Information
11.7.2 Roche Overview
11.7.3 Roche Prostate Cancer Diagnostics Sales, Price, Revenue and Gross Margin (2016-2021)
11.7.4 Roche Prostate Cancer Diagnostics Product Description
11.7.5 Roche Related Developments
11.8 MDx Health
11.8.1 MDx Health Corporation Information
11.8.2 MDx Health Overview
11.8.3 MDx Health Prostate Cancer Diagnostics Sales, Price, Revenue and Gross Margin (2016-2021)
11.8.4 MDx Health Prostate Cancer Diagnostics Product Description
11.8.5 MDx Health Related Developments
11.9 Beckman Coulter
11.9.1 Beckman Coulter Corporation Information
11.9.2 Beckman Coulter Overview
11.9.3 Beckman Coulter Prostate Cancer Diagnostics Sales, Price, Revenue and Gross Margin (2016-2021)
11.9.4 Beckman Coulter Prostate Cancer Diagnostics Product Description
11.9.5 Beckman Coulter Related Developments
11.10 Myriad Genetics
11.10.1 Myriad Genetics Corporation Information
11.10.2 Myriad Genetics Overview
11.10.3 Myriad Genetics Prostate Cancer Diagnostics Sales, Price, Revenue and Gross Margin (2016-2021)
11.10.4 Myriad Genetics Prostate Cancer Diagnostics Product Description
11.10.5 Myriad Genetics Related Developments
11.1 Genomic Health
11.1.1 Genomic Health Corporation Information
11.1.2 Genomic Health Overview
11.1.3 Genomic Health Prostate Cancer Diagnostics Sales, Price, Revenue and Gross Margin (2016-2021)
11.1.4 Genomic Health Prostate Cancer Diagnostics Product Description
11.1.5 Genomic Health Related Developments
12 Value Chain and Sales Channels Analysis
12.1 Prostate Cancer Diagnostics Value Chain Analysis
12.2 Prostate Cancer Diagnostics Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Prostate Cancer Diagnostics Production Mode & Process
12.4 Prostate Cancer Diagnostics Sales and Marketing
12.4.1 Prostate Cancer Diagnostics Sales Channels
12.4.2 Prostate Cancer Diagnostics Distributors
12.5 Prostate Cancer Diagnostics Customers
13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis
13.1 Prostate Cancer Diagnostics Industry Trends
13.2 Prostate Cancer Diagnostics Market Drivers
13.3 Prostate Cancer Diagnostics Market Challenges
13.4 Prostate Cancer Diagnostics Market Restraints
14 Key Findings in The Global Prostate Cancer Diagnostics Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer
List of Tables
Table 1. Global Prostate Cancer Diagnostics Market Size Growth Rate by Type, 2016 VS 2021 VS 2027 (US$ Million)
Table 2. Major Manufacturers of Tumor Biomarker Tests
Table 3. Major Manufacturers of Imaging
Table 4. Major Manufacturers of Biopsy
Table 5. Major Manufacturers of Other
Table 6. Global Prostate Cancer Diagnostics Market Size Growth Rate by Application, 2016 VS 2021 VS 2027 (US$ Million)
Table 7. Global Prostate Cancer Diagnostics Revenue by Region: 2016 VS 2021 VS 2027 (US$ Million)
Table 8. Global Prostate Cancer Diagnostics Sales by Region (2016-2021) & (K Units)
Table 9. Global Prostate Cancer Diagnostics Sales Market Share by Region (2016-2021)
Table 10. Global Prostate Cancer Diagnostics Sales by Region (2016-2021) & (K Units)
Table 11. Global Prostate Cancer Diagnostics Sales Market Share by Region (2022-2027)
Table 12. Global Prostate Cancer Diagnostics Revenue by Region (2016-2021) & (US$ Million)
Table 13. Global Prostate Cancer Diagnostics Revenue Market Share by Region (2016-2021)
Table 14. Global Prostate Cancer Diagnostics Revenue by Region (2022-2027) & (US$ Million)
Table 15. Global Prostate Cancer Diagnostics Revenue Market Share by Region (2022-2027)
Table 16. Global Prostate Cancer Diagnostics Sales by Manufacturers (2016-2021) & (K Units)
Table 17. Global Prostate Cancer Diagnostics Sales Share by Manufacturers (2016-2021)
Table 18. Global Prostate Cancer Diagnostics Revenue by Manufacturers (2016-2021) & (US$ Million)
Table 19. Global Prostate Cancer Diagnostics Revenue Share by Manufacturers (2016-2021)
Table 20. Prostate Cancer Diagnostics Price by Manufacturers 2016-2021 (USD/Unit)
Table 21. Global Prostate Cancer Diagnostics Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 22. Global Prostate Cancer Diagnostics by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Prostate Cancer Diagnostics as of 2020)
Table 23. Prostate Cancer Diagnostics Manufacturing Base Distribution and Headquarters
Table 24. Manufacturers Prostate Cancer Diagnostics Product Offered
Table 25. Date of Manufacturers Enter into Prostate Cancer Diagnostics Market
Table 26. Mergers & Acquisitions, Expansion Plans
Table 27. Global Prostate Cancer Diagnostics Sales by Type (2016-2021) & (K Units)
Table 28. Global Prostate Cancer Diagnostics Sales by Type (2022-2027) & (K Units)
Table 29. Global Prostate Cancer Diagnostics Sales Share by Type (2016-2021)
Table 30. Global Prostate Cancer Diagnostics Sales Share by Type (2022-2027)
Table 31. Global Prostate Cancer Diagnostics Revenue by Type (2016-2021) & (US$ Million)
Table 32. Global Prostate Cancer Diagnostics Revenue by Type (2022-2027) & (US$ Million)
Table 33. Global Prostate Cancer Diagnostics Revenue Share by Type (2016-2021)
Table 34. Global Prostate Cancer Diagnostics Revenue Share by Type (2022-2027)
Table 35. Prostate Cancer Diagnostics Price by Type (2016-2021) & (USD/Unit)
Table 36. Global Prostate Cancer Diagnostics Price Forecast by Type (2022-2027) & (USD/Unit)
Table 37. Global Prostate Cancer Diagnostics Sales by Application (2016-2021) & (K Units)
Table 38. Global Prostate Cancer Diagnostics Sales by Application (2022-2027) & (K Units)
Table 39. Global Prostate Cancer Diagnostics Sales Share by Application (2016-2021)
Table 40. Global Prostate Cancer Diagnostics Sales Share by Application (2022-2027)
Table 41. Global Prostate Cancer Diagnostics Revenue by Application (2016-2021) & (US$ Million)
Table 42. Global Prostate Cancer Diagnostics Revenue by Application (2022-2027) & (US$ Million)
Table 43. Global Prostate Cancer Diagnostics Revenue Share by Application (2016-2021)
Table 44. Global Prostate Cancer Diagnostics Revenue Share by Application (2022-2027)
Table 45. Prostate Cancer Diagnostics Price by Application (2016-2021) & (USD/Unit)
Table 46. Global Prostate Cancer Diagnostics Price Forecast by Application (2022-2027) & (USD/Unit)
Table 47. North America Prostate Cancer Diagnostics Sales by Type (2016-2021) & (K Units)
Table 48. North America Prostate Cancer Diagnostics Sales by Type (2022-2027) & (K Units)
Table 49. North America Prostate Cancer Diagnostics Revenue by Type (2016-2021) & (US$ Million)
Table 50. North America Prostate Cancer Diagnostics Revenue by Type (2022-2027) & (US$ Million)
Table 51. North America Prostate Cancer Diagnostics Sales by Application (2016-2021) & (K Units)
Table 52. North America Prostate Cancer Diagnostics Sales by Application (2022-2027) & (K Units)
Table 53. North America Prostate Cancer Diagnostics Revenue by Application (2016-2021) & (US$ Million)
Table 54. North America Prostate Cancer Diagnostics Revenue by Application (2022-2027) & (US$ Million)
Table 55. North America Prostate Cancer Diagnostics Sales by Country (2016-2021) & (K Units)
Table 56. North America Prostate Cancer Diagnostics Sales by Country (2022-2027) & (K Units)
Table 57. North America Prostate Cancer Diagnostics Revenue by Country (2016-2021) & (US$ Million)
Table 58. North America Prostate Cancer Diagnostics Revenue by Country (2022-2027) & (US$ Million)
Table 59. Europe Prostate Cancer Diagnostics Sales by Type (2016-2021) & (K Units)
Table 60. Europe Prostate Cancer Diagnostics Sales by Type (2022-2027) & (K Units)
Table 61. Europe Prostate Cancer Diagnostics Revenue by Type (2016-2021) & (US$ Million)
Table 62. Europe Prostate Cancer Diagnostics Revenue by Type (2022-2027) & (US$ Million)
Table 63. Europe Prostate Cancer Diagnostics Sales by Application (2016-2021) & (K Units)
Table 64. Europe Prostate Cancer Diagnostics Sales by Application (2022-2027) & (K Units)
Table 65. Europe Prostate Cancer Diagnostics Revenue by Application (2016-2021) & (US$ Million)
Table 66. Europe Prostate Cancer Diagnostics Revenue by Application (2022-2027) & (US$ Million)
Table 67. Europe Prostate Cancer Diagnostics Sales by Country (2016-2021) & (K Units)
Table 68. Europe Prostate Cancer Diagnostics Sales by Country (2022-2027) & (K Units)
Table 69. Europe Prostate Cancer Diagnostics Revenue by Country (2016-2021) & (US$ Million)
Table 70. Europe Prostate Cancer Diagnostics Revenue by Country (2022-2027) & (US$ Million)
Table 71. Asia Pacific Prostate Cancer Diagnostics Sales by Type (2016-2021) & (K Units)
Table 72. Asia Pacific Prostate Cancer Diagnostics Sales by Type (2022-2027) & (K Units)
Table 73. Asia Pacific Prostate Cancer Diagnostics Revenue by Type (2016-2021) & (US$ Million)
Table 74. Asia Pacific Prostate Cancer Diagnostics Revenue by Type (2022-2027) & (US$ Million)
Table 75. Asia Pacific Prostate Cancer Diagnostics Sales by Application (2016-2021) & (K Units)
Table 76. Asia Pacific Prostate Cancer Diagnostics Sales by Application (2022-2027) & (K Units)
Table 77. Asia Pacific Prostate Cancer Diagnostics Revenue by Application (2016-2021) & (US$ Million)
Table 78. Asia Pacific Prostate Cancer Diagnostics Revenue by Application (2022-2027) & (US$ Million)
Table 79. Asia Pacific Prostate Cancer Diagnostics Sales by Region (2016-2021) & (K Units)
Table 80. Asia Pacific Prostate Cancer Diagnostics Sales by Region (2022-2027) & (K Units)
Table 81. Asia Pacific Prostate Cancer Diagnostics Revenue by Region (2016-2021) & (US$ Million)
Table 82. Asia Pacific Prostate Cancer Diagnostics Revenue by Region (2022-2027) & (US$ Million)
Table 83. Latin America Prostate Cancer Diagnostics Sales by Type (2016-2021) & (K Units)
Table 84. Latin America Prostate Cancer Diagnostics Sales by Type (2022-2027) & (K Units)
Table 85. Latin America Prostate Cancer Diagnostics Revenue by Type (2016-2021) & (US$ Million)
Table 86. Latin America Prostate Cancer Diagnostics Revenue by Type (2022-2027) & (US$ Million)
Table 87. Latin America Prostate Cancer Diagnostics Sales by Application (2016-2021) & (K Units)
Table 88. Latin America Prostate Cancer Diagnostics Sales by Application (2022-2027) & (K Units)
Table 89. Latin America Prostate Cancer Diagnostics Revenue by Application (2016-2021) & (US$ Million)
Table 90. Latin America Prostate Cancer Diagnostics Revenue by Application (2022-2027) & (US$ Million)
Table 91. Latin America Prostate Cancer Diagnostics Sales by Country (2016-2021) & (K Units)
Table 92. Latin America Prostate Cancer Diagnostics Sales by Country (2022-2027) & (K Units)
Table 93. Latin America Prostate Cancer Diagnostics Revenue by Country (2016-2021) & (US$ Million)
Table 94. Latin America Prostate Cancer Diagnostics Revenue by Country (2022-2027) & (US$ Million)
Table 95. Middle East and Africa Prostate Cancer Diagnostics Sales by Type (2016-2021) & (K Units)
Table 96. Middle East and Africa Prostate Cancer Diagnostics Sales by Type (2022-2027) & (K Units)
Table 97. Middle East and Africa Prostate Cancer Diagnostics Revenue by Type (2016-2021) & (US$ Million)
Table 98. Middle East and Africa Prostate Cancer Diagnostics Revenue by Type (2022-2027) & (US$ Million)
Table 99. Middle East and Africa Prostate Cancer Diagnostics Sales by Application (2016-2021) & (K Units)
Table 100. Middle East and Africa Prostate Cancer Diagnostics Sales by Application (2022-2027) & (K Units)
Table 101. Middle East and Africa Prostate Cancer Diagnostics Revenue by Application (2016-2021) & (US$ Million)
Table 102. Middle East and Africa Prostate Cancer Diagnostics Revenue by Application (2022-2027) & (US$ Million)
Table 103. Middle East and Africa Prostate Cancer Diagnostics Sales by Country (2016-2021) & (K Units)
Table 104. Middle East and Africa Prostate Cancer Diagnostics Sales by Country (2022-2027) & (K Units)
Table 105. Middle East and Africa Prostate Cancer Diagnostics Revenue by Country (2016-2021) & (US$ Million)
Table 106. Middle East and Africa Prostate Cancer Diagnostics Revenue by Country (2022-2027) & (US$ Million)
Table 107. Genomic Health Corporation Information
Table 108. Genomic Health Description and Major Businesses
Table 109. Genomic Health Prostate Cancer Diagnostics Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2016-2021)
Table 110. Genomic Health Prostate Cancer Diagnostics Product
Table 111. Genomic Health Recent Developments
Table 112. Abbott Corporation Information
Table 113. Abbott Description and Major Businesses
Table 114. Abbott Prostate Cancer Diagnostics Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2016-2021)
Table 115. Abbott Prostate Cancer Diagnostics Product
Table 116. Abbott Recent Developments
Table 117. OPKO Corporation Information
Table 118. OPKO Description and Major Businesses
Table 119. OPKO Prostate Cancer Diagnostics Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2016-2021)
Table 120. OPKO Prostate Cancer Diagnostics Product
Table 121. OPKO Recent Developments
Table 122. Siemens Healthcare Corporation Information
Table 123. Siemens Healthcare Description and Major Businesses
Table 124. Siemens Healthcare Prostate Cancer Diagnostics Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2016-2021)
Table 125. Siemens Healthcare Prostate Cancer Diagnostics Product
Table 126. Siemens Healthcare Recent Developments
Table 127. DiaSorin Corporation Information
Table 128. DiaSorin Description and Major Businesses
Table 129. DiaSorin Prostate Cancer Diagnostics Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2016-2021)
Table 130. DiaSorin Prostate Cancer Diagnostics Product
Table 131. DiaSorin Recent Developments
Table 132. BioMeriux Corporation Information
Table 133. BioMeriux Description and Major Businesses
Table 134. BioMeriux Prostate Cancer Diagnostics Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2016-2021)
Table 135. BioMeriux Prostate Cancer Diagnostics Product
Table 136. BioMeriux Recent Developments
Table 137. Roche Corporation Information
Table 138. Roche Description and Major Businesses
Table 139. Roche Prostate Cancer Diagnostics Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2016-2021)
Table 140. Roche Prostate Cancer Diagnostics Product
Table 141. Roche Recent Developments
Table 142. MDx Health Corporation Information
Table 143. MDx Health Description and Major Businesses
Table 144. MDx Health Prostate Cancer Diagnostics Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2016-2021)
Table 145. MDx Health Prostate Cancer Diagnostics Product
Table 146. MDx Health Recent Developments
Table 147. Beckman Coulter Corporation Information
Table 148. Beckman Coulter Description and Major Businesses
Table 149. Beckman Coulter Prostate Cancer Diagnostics Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2016-2021)
Table 150. Beckman Coulter Prostate Cancer Diagnostics Product
Table 151. Beckman Coulter Recent Developments
Table 152. Myriad Genetics Corporation Information
Table 153. Myriad Genetics Description and Major Businesses
Table 154. Myriad Genetics Prostate Cancer Diagnostics Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2016-2021)
Table 155. Myriad Genetics Prostate Cancer Diagnostics Product
Table 156. Myriad Genetics Recent Developments
Table 157. Ambry Genetics Corporation Information
Table 158. Ambry Genetics Description and Major Businesses
Table 159. Ambry Genetics Prostate Cancer Diagnostics Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2016-2021)
Table 160. Ambry Genetics Prostate Cancer Diagnostics Product
Table 161. Ambry Genetics Recent Developments
Table 162. Key Raw Materials Lists
Table 163. Raw Materials Key Suppliers Lists
Table 164. Prostate Cancer Diagnostics Distributors List
Table 165. Prostate Cancer Diagnostics Customers List
Table 166. Prostate Cancer Diagnostics Market Trends
Table 167. Prostate Cancer Diagnostics Market Drivers
Table 168. Prostate Cancer Diagnostics Market Challenges
Table 169. Prostate Cancer Diagnostics Market Restraints
Table 170. Research Programs/Design for This Report
Table 171. Key Data Information from Secondary Sources
Table 172. Key Data Information from Primary Sources
List of Figures
Figure 1. Prostate Cancer Diagnostics Product Picture
Figure 2. Global Prostate Cancer Diagnostics Market Share by Type in 2020 & 2027
Figure 3. Tumor Biomarker Tests Product Picture
Figure 4. Imaging Product Picture
Figure 5. Biopsy Product Picture
Figure 6. Other Product Picture
Figure 7. Global Prostate Cancer Diagnostics Sales Market Share by Application in 2020 & 2027
Figure 8. age Below 55
Figure 9. age 55-75
Figure 10. age Above 75
Figure 11. Prostate Cancer Diagnostics Report Years Considered
Figure 12. Global Prostate Cancer Diagnostics Sales 2016-2027 (K Units)
Figure 13. Global Prostate Cancer Diagnostics Revenue, (US$ Million), 2016 VS 2021 VS 2027
Figure 14. Global Prostate Cancer Diagnostics Revenue 2016-2027 (US$ Million)
Figure 15. Global Prostate Cancer Diagnostics Revenue Market Share by Region in Percentage: 2020 Versus 2027
Figure 16. Global Prostate Cancer Diagnostics Sales Market Share by Region (2016-2021)
Figure 17. Global Prostate Cancer Diagnostics Sales Market Share by Region (2022-2027)
Figure 18. North America Prostate Cancer Diagnostics Sales YoY (2016-2027) & (K Units)
Figure 19. North America Prostate Cancer Diagnostics Revenue YoY (2016-2027) & (US$ Million)
Figure 20. Europe Prostate Cancer Diagnostics Sales YoY (2016-2027) & (K Units)
Figure 21. Europe Prostate Cancer Diagnostics Revenue YoY (2016-2027) & (US$ Million)
Figure 22. Asia-Pacific Prostate Cancer Diagnostics Sales YoY (2016-2027) & (K Units)
Figure 23. Asia-Pacific Prostate Cancer Diagnostics Revenue YoY (2016-2027) & (US$ Million)
Figure 24. Latin America Prostate Cancer Diagnostics Sales YoY (2016-2027) & (K Units)
Figure 25. Latin America Prostate Cancer Diagnostics Revenue YoY (2016-2027) & (US$ Million)
Figure 26. Middle East & Africa Prostate Cancer Diagnostics Sales YoY (2016-2027) & (K Units)
Figure 27. Middle East & Africa Prostate Cancer Diagnostics Revenue YoY (2016-2027) & (US$ Million)
Figure 28. The Top 10 and Top 5 Players Market Share by Prostate Cancer Diagnostics Sales in 2020
Figure 29. The Top 10 and Top 5 Players Market Share by Prostate Cancer Diagnostics Revenue in 2020
Figure 30. Prostate Cancer Diagnostics Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2016 VS 2020
Figure 31. Global Prostate Cancer Diagnostics Sales Market Share by Type (2016-2027)
Figure 32. Global Prostate Cancer Diagnostics Revenue Market Share by Type (2016-2027)
Figure 33. Global Prostate Cancer Diagnostics Sales Market Share by Application (2016-2027)
Figure 34. Global Prostate Cancer Diagnostics Revenue Market Share by Application (2016-2027)
Figure 35. North America Prostate Cancer Diagnostics Sales Market Share by Type (2016-2027)
Figure 36. North America Prostate Cancer Diagnostics Revenue Market Share by Type (2016-2027)
Figure 37. North America Prostate Cancer Diagnostics Sales Market Share by Application (2016-2027)
Figure 38. North America Prostate Cancer Diagnostics Revenue Market Share by Application (2016-2027)
Figure 39. North America Prostate Cancer Diagnostics Sales Share by Country (2016-2027)
Figure 40. North America Prostate Cancer Diagnostics Revenue Share by Country (2016-2027)
Figure 41. U.S. Prostate Cancer Diagnostics Revenue (2016-2027) & (US$ Million)
Figure 42. Canada Prostate Cancer Diagnostics Revenue (2016-2027) & (US$ Million)
Figure 43. Europe Prostate Cancer Diagnostics Sales Market Share by Type (2016-2027)
Figure 44. Europe Prostate Cancer Diagnostics Revenue Market Share by Type (2016-2027)
Figure 45. Europe Prostate Cancer Diagnostics Sales Market Share by Application (2016-2027)
Figure 46. Europe Prostate Cancer Diagnostics Revenue Market Share by Application (2016-2027)
Figure 47. Europe Prostate Cancer Diagnostics Sales Share by Country (2016-2027)
Figure 48. Europe Prostate Cancer Diagnostics Revenue Share by Country (2016-2027)
Figure 49. Germany Prostate Cancer Diagnostics Revenue (2016-2027) & (US$ Million)
Figure 50. France Prostate Ca
  • Checkpoint Inhibitors for Treating Cancer Market - Global Outlook and Forecast 2021-2027
    Published: 01-Jun-2021        Price: US 3250 Onwards        Pages: 90
    This report contains market size and forecasts of Checkpoint Inhibitors for Treating Cancer in global, including the following market information: Global Checkpoint Inhibitors for Treating Cancer Market Revenue, 2016-2021, 2022-2027, ($ millions) Global Checkpoint Inhibitors for Treating Cancer Market Sales, 2016-2021, 2022-2027, (g) Global top five Checkpoint Inhibitors for Treating Cancer companies in 2020 (%) The global Checkpoint Inhibitors for Treating Cancer mar......
  • HPV Testing Market - Global Outlook and Forecast 2021-2027
    Published: 01-Jun-2021        Price: US 3250 Onwards        Pages: 94
    This report contains market size and forecasts of HPV Testing in Global, including the following market information: Global HPV Testing Market Revenue, 2016-2021, 2022-2027, ($ millions) Global top five companies in 2020 (%) The global HPV Testing market was valued at 762.5 million in 2020 and is projected to reach US$ 1035.1 million by 2027, at a CAGR of 7.9% during the forecast period. MARKET MONITOR GLOBAL, INC (MMG) has surveyed the HPV Testing companies, an......
  • Global Checkpoint Inhibitors for Treating Cancer Market Insights and Forecast to 2027
    Published: 28-May-2021        Price: US 4900 Onwards        Pages: 111
    Checkpoint Inhibitors for Treating Cancer market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Checkpoint Inhibitors for Treating Cancer market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2016-2027. Segment by Type - PD-1 Inhibitors - PD-L1 Inhibitors - CTLA-4 Inhi......
  • Global PSA Test Market Insights and Forecast to 2027
    Published: 27-May-2021        Price: US 4900 Onwards        Pages: 119
    PSA Test market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global PSA Test market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2016-2027. Segment by Type - CLIA - ELISA - Others Segment by Application - Screening - Post-treatment Monitoring......
  • 2020-2025 Global Prostate Cancer Diagnostics Market Report - Production and Consumption Professional Analysis (Impact of COVID-19)
    Published: 13-May-2021        Price: US 3360 Onwards        Pages: 132
    This report elaborates the market size, market characteristics, and market growth of the Prostate Cancer Diagnostics industry, and breaks down according to the type, application, and consumption area of Prostate Cancer Diagnostics. The report also conducted a PESTEL analysis of the industry to study the main influencing factors and entry barriers of the industry. In Chapter 3.4 of the report, the impact of the COVID-19 outbreak on the industry was fully assessed. Fully ris......
  • Global Prostate Cancer Diagnostics Market Insights and Forecast to 2027
    Published: 12-May-2021        Price: US 4900 Onwards        Pages: 116
    Prostate Cancer Diagnostics market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Prostate Cancer Diagnostics market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2016-2027. Segment by Type - Tumor Biomarker Tests - Imaging - Biopsy - Other Segme......
  • Global Prostate Cancer Diagnostics Market Growth (Status and Outlook) 2021-2026
    Published: 11-May-2021        Price: US 3660 Onwards        Pages: 105
    According to this latest study, the 2021 growth of Prostate Cancer Diagnostics will have significant change from previous year. By the most conservative estimates of global Prostate Cancer Diagnostics market size (most likely outcome) will be a year-over-year revenue growth rate of XX% in 2021, from US$ 12250 million in 2020. Over the next five years the Prostate Cancer Diagnostics market will register a 8.1% CAGR in terms of revenue, the global market size will reach US$ 16750 million by 2026.......
  • 2020-2025 Global Lung Cancer Liquid Biopsy Market Report - Production and Consumption Professional Analysis (Impact of COVID-19)
    Published: 06-May-2021        Price: US 3360 Onwards        Pages: 115
    This report elaborates the market size, market characteristics, and market growth of the Lung Cancer Liquid Biopsy industry, and breaks down according to the type, application, and consumption area of Lung Cancer Liquid Biopsy. The report also conducted a PESTEL analysis of the industry to study the main influencing factors and entry barriers of the industry. In Chapter 3.4 of the report, the impact of the COVID-19 outbreak on the industry was fully assessed. Fully risk as......
  • Global Cancer Diagnostics Partnering Terms and Agreements 2014-2021
    Published: 01-May-2021        Price: US 3495 Onwards        Pages: 550
    The Global Cancer Diagnostics Partnering Terms and Agreements 2014-2021 report provides an understanding and access to the cancer diagnostics partnering deals and agreements entered into by the worlds leading healthcare companies. Trends in cancer diagnostics partnering deals Disclosed headlines, upfronts, milestones and royalties by stage of development Cancer diagnostics partnering contract documents Top cancer diagnostics deals by value This ......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs